| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.04B | +9.6% |
| Cost of Revenue | $1.56B | +6.3% |
| Gross Profit | $1.47B | +13.3% |
| R&D Expense | $194.0M | +4.9% |
| SG&A Expense | $357.0M | +8.8% |
| Operating Income | $919.0M | +17.2% |
| Pre-tax Income | $827.0M | +28.2% |
| Income Tax | $154.0M | +35.1% |
| Net Income | $673.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $555.0M | +139.2% |
| Accounts Receivable | $356.0M | -1.9% |
| Inventory | $276.0M | +23.2% |
| Current Assets | $1.25B | +44.3% |
| Total Assets | $5.03B | +7.6% |
| Current Liabilities | $501.0M | +4.4% |
| Long-term Debt | $2.52B | -0.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $784.0M | +19.3% |
| Capital Expenditures | $125.0M | -25.1% |
| Investing Cash Flow | -$129.0M | +29.5% |
| Financing Cash Flow | -$332.0M | +9.5% |
| Free Cash Flow | $659.0M | +34.5% |
| +26.7% |
| EPS (Basic) | $7.48 | +35.3% |
| EPS (Diluted) | $7.40 | +33.8% |
| Total Liabilities |
| $3.79B |
| -0.1% |
| Stockholders' Equity | $1.23B | +41.1% |